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Purpose: Despite ubiquitous expression of the keratoepithelin (KE) protein encoded by the transforming growth factor
beta induced/beta induced gene human clone 3 (TGFBI/BIGH3) gene, corneal dystrophies are restricted to the cornea,
and no other tissues are affected. We investigated the role of TGFBI/BIGH3 in Groenouw corneal dystrophies by
generating transgenic mice overexpressing TGFBI/BIGH3 containing the R555W mutation.
Methods: Transgenic animals expressing the Groenouw mutation of human TGFBI/BIGH3 were generated using lentiviral
vectors. The line expressed TGFBI/BIGH3 containing the R555W mutation under the control of the phosphoglycerate
kinase (PGK) promoter. Expression of the transgene was monitored by Southern and western blotting and by RT–PCR.
Electroretinogram analysis was performed and four mice were subjected to complete necroscopy.
Results: Transgene expression was observed in different organs although without specific expression in the cornea. The
overall morphology of the transgenic animals was not severely affected by KE overexpression. However, we observed an
age-dependent retinal degeneration both functionally and histologically. Female-specific follicular hyperplasia in the
spleen and increased levels of lipofuscin in the adrenal gland were also seen in transgenic animals.
Conclusions: Cellular degeneration in the retina of transgenic animals suggest that perturbation of the transforming growth
factor beta (TGFβ) family regulation may affect photoreceptor survival and may induce possible accelerated aging in
several tissues. No corneal phenotype could be observed, probably due to the lack of transgene expression in this tissue.
Human corneal dystrophies (HCD) are rare hereditary
diseases  characterized  by  bilateral  loss  of  corneal
transparency due to the slow accumulation of amyloid as well
as non-amyloid deposits. Symptoms may become present as
early  as  birth,  but  more  frequently  they  develop  during
adolescence and gradually progress throughout life. We and
others  have  mapped  four  different  forms  of  HCD  to
chromosome  5q31  [1]  and  subsequently  recognized  that
mutations  in  the  transforming  growth  factor  beta-induced
gene (TGFBI/BIGH3) were the causes of these diseases [2].
Although mutations at two specific amino acids (R124 and
R555) are responsible for the great majority of the cases,
isolated families have been described with mutations in other
parts of the gene [3,4].
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Studies  of  TGFBI/BIGH3-related  HCD  are  of  great
interest,  and  while  keratoepithelin  (KE),  the  product  of
TGFBI/BIGH3, is ubiquitously expressed except in the brain,
it is still not understood why KE deposits only occur in corneas
[5].  In  this  report,  we  describe  a  transgenic  mouse  line
expressing an R555W mutated form of human TGFBI/BIGH3
in an attempt to generate a model for the Groenouw type I
HCD. Extensive postmortem analyses included macroscopic
and histopathologic analyses of organs and measures of the
principal metabolic enzymes. Our data indicate that transgene
expression  of  TGFBI/BIGH3  induced  an  age-dependent
retinal  degeneration,  associated  with  concomitant
significantly  attenuated  cone  and  rod  responses.  Female
animals also displayed a mild follicular hyperplasia in the
spleen  and  lipofuscin  expression  in  the  adrenal  glands,
suggesting  an  accelerated  aging  process.  No  other
histopathologic abnormalities were noticed in the transgenic
animals compared to control mice. In particular, no transgenic
RNA expression was observed in the corneas of these animals.
MATERIAL AND METHODS
Lentivirus  generation:  Recombinant  lentiviral  particles
containing a vesicular stomatitis virus G protein (VSV-G)
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1129envelop were produced by transient transfection of 293T cells
as  previously  described  [6].  Briefly,  293T  cells  were
transfected  with  the  different  plasmids  using  calcium
phosphate, the medium harvested 36 h later and centrifuged
at  70,000x  g.  Viral  supernatants  were  concentrated  by  a
second ultracentrifugation at 70,000x g for 90 min at 4 °C.
The viral pellets were resuspended in a minimal of volume of
PBS  containing  10  mg/ml  bovine  serum  albumin  (BSA).
Aliquots of 5 µl were then stored at −70 °C until further use.
Total particle concentration of the viral stocks was estimated
by quantification of the p24 capsid protein using Retro-TEK
HIV-1  p24  Antigen  ELISA  kit  (ZeptoMetrixCorporation,
Buffalo, New York).
High transduction efficiency was observed in corneal
endothelial cells in vivo, using an HIV-1-derived lentivirus
with a cytomegalovirus immediate early promoter (CMV). A
similar efficacy was reported for rat, ovine, and human cornea
explants infected in vitro with a lentiviral vector carrying a
simian virus (SV) promoter [7,8]. Previous results have shown
similar  efficacy  in  mouse  cornea  using  HIV  or  equine
infectious anemia virus (EIAV) vectors containing the vectors
containing  the  VSV-G  envelop  (VSVG)  envelop  and  the
CMV vector [9]. In cell culture, EIAV has also shown a strong
efficiency to transduce human endothelial cells using a CMV
promoter and the VSV-G envelop [10].
A  human  TGFBI/BIGH3  cDNA  with  the  R555W
Groenouw  mutation  was  ligated  into  BamHI  sites  of  a
replication-deficient, self-inactivating plasmid (pSIN) under
the regulation of the mouse phosphoglycerate kinase promoter
(PGK; Figure 1). The PGK promoter is a ubiquitous promoter
that was successfully used with lentiviral vectors in many
tissues [11,12]. Since the GC-rich sequence of the mouse PGK
promoter contains only three ATG triplets, this promoter is
particularly suitable for lentiviral constructions as compared
to other ubiquitous promoters [13]. Presence or absence of
mutation was confirmed by direct sequencing of the insert.
Lentiviral vector preparation: A replication-deficient, self-
inactivating  (SIN)  backbone  was  obtained  from  Patrick
Aebischer  (Ecole  Polytechnique  Fédérale  de  Lausanne
[EPFL], Lausanne, Switzerland). The transgene encoding the
human TGFBI/BIGH3 cDNA was inserted into a backbone
containing  the  SIN  followed  by  the  elongation  factor-1
Figure  1.  Lentiviral  backbone  containing  the  phosphoglycerate
kinase promoter and the post-transcriptional regulatory element of
woodchuck hepatitis virus. Note the Groenouw (R555W) mutation,
the localization of the probe used for Southern blotting, and the
unique  BamHI  site  (black  arrow).  In  the  figure,  n  indicates  the
number of founders obtained for the construct.
minimum  promoter  and  the  woodchuck  hepatitis  post-
transcriptional regulatory elements (SIN-W-EFs) to generate
the lentiviral vector LV_BIGH3. The lentiviral vector was
produced as described above and previously by Naldini [14].
Generation of transgenic animals: All procedures implicating
mice manipulation were performed in agreement with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and were approved by the local Veterinary
Committee Office on Use and Care of Animals in Research
of Canton Vaud, Lausanne, Switzerland. Mice (120 total, 60
males and 60 females) were maintained on a 14:10 light-dark
cycle under standard housing conditions. Water and standard
high  protein  food  (Kliba,  Switzerland)  were  available  at
libitum.
Transgenesis  was  performed  according  to  standard
protocols  [15].  Briefly,  four-week-old  National  Marine
Research Institute (NMRI) females were superovulated by
intraperitoneal  injection  of  5U  pregnant  mare’s  serum
gonadotropin followed by injection of 5U human chorionic
gonadotropin 48 h later. Superovulated females were mated
with NMRI males, and embryos were collected at zygote stage
on  the  following  day.  Zygotes  were  then  immediately
microinjected  into  the  perivitelline  space  with  10-100
picoliters  of  about  109  transduction  unit/ml  lentiviral
preparation and incubated in M16 medium (Sigma, St. Louis,
MO) at 37 °C and 5% CO2 atmosphere. On the following day,
two-cell stage embryos were selected and transferred into the
oviduct of 3 pseudopregnant NMRI females.
NMRI mice are widely used as experimental models in
many fields of general biology. Albino NMRI mice are widely
used in transgenesis since embryos derived from this strain
are more resistant than inbred mouse embryos such as C57/
BL6  and  their  use  results  in  a  higher  transgenesis  rate.
Moreover,  outbred  mice  embryos  are  more  resistant  than
inbred mice embryos and lead to a higher transgenesis rate.
RNA extraction: Several organs including retina and cornea
were removed from euthanized mice and directly placed in
ice. Euthanasia was performed by neck dislocation. Total
RNA was extracted using Trizol® reagent according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA). RNA
concentration and purity were measured using RiboGreen®
(Molecular  Probes,  Eugene,  OR)  according  to  the
manufacturer’s instructions.
cDNA synthesis: Equal amounts (1 µg) of RNA were used to
synthesize cDNA using StrataScript Reverse Transcriptase
according to the manufacturer’s instructions (Stratagene, La
Jolla, CA).
Genomic DNA extraction: Genomic DNA was obtained from
mouse tail biopsies as follows: cut tail was transferred into
lysis buffer, which contained 100 mM TrisHCl, pH 8.5, 5 mM
EDTA, 0.2% sodium dodecyl sulfate (SDS), 200 mM NaCl,
and 100 µg proteinase K/ml, and incubated in a rotating shaker
at  56  °C  overnight.  After  complete  lysis,  samples  were
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isopropanol. After a second 2 min centrifugation, supernatant
was removed and the pellet was dissolved in 150 µl 10 mM
TrisHCl and 0.1 mM EDTA, pH 7.5, and incubated at 80 °C
for 4 min. The obtained genomic DNA was directly used to
perform PCRs.
Transgene  integration,  expression,  and  monitoring:
Transgene integration was determined from biopsies by PCR
amplification of TGFBI/BIGH3. Genomic DNA (500 ng or 1
µg),  obtained  as  described  in  the  previous  section,  was
amplified.  If  not  otherwise  stated,  the  conditions  were  as
follows: a first incubation of 5 min at 94 °C, then 35 cycles of
1 min at 94 °C, 1 min at 56 °C and 3 min at 72 °C, and finally
a last extension of 10 min at 72 °C. The following primers
were used: Big-Big_F, Big-Big_R, PGK-BIG_F, and PGK-
BIG_R  (Table  1).  Since  the  human  transgene  sequence
contained a unique BamH1 site in a specific PCR-amplified
region, transgene transcription was monitored by digestion of
the PCR amplified cDNA produced by reverse-transcribed
RNA.  PCR  was  performed  from  100  to  500  ng  cDNA
amplified  by  Hotstart  Taq  polymerase  (Qiagen,  Hilden,
Germany), with the primers 227F and 649R (Table 1) and the
following conditions: a first incubation of 5 min at 95 °C, then
30 cycles of 1 min at 95 °C, 1 min at 55 °C and 1 min at 72
°C, with a final extension of 10 min at 72 °C. BamHI digestion
was performed from 0.1 to 1 µg gel purified PCR product
incubated 8-16 h at 37 °C with 1 unit of enzyme in Roche B
buffer.  Digestion  of  endogenous  mouse  TGFBI/BIGH3
resulted  in  a  product  of  about  500  bp  whereas  BamHI
digestion of transgenic (human) TGFBI/BIGH3 resulted in
two bands of about 300 bp and 200 bp.
The number of transgene integration sites was monitored
by Southern blot. Genomic DNA obtained was digested with
EcoRI overnight at 37 °C. The digested DNA was precipitated
with  3M  sodium  acetate  (pH  5.2)/EtOH  on  ice  and
resuspended in trishydroxymethylaminomethane – ethylene
diamine tetraacetic acid (TE) buffer. A full-length TGFBI/
TABLE 1. LIST OF ALL THE PRIMERS USED IN THE GENERATION OF A TRANSGENIC MOUSE LINE.
Primer name 5'->3'
Big-Big_F AGTCATCAGCTACGAGTGCT
Big-Big_R CCCATTAGGATAGTGGTGG
PGK-BIG_F GATCCATCCAGGCGGCCGTG
PGK-BIG_R GAGGGTCATGCCGTGTTTCA
227F ACTTCACCAACTGCAAGCAG
649R TCTGGATGTTGGAATTCTGG
LTR1-biotin CTTAATACTGACGCTCTCGCACCA
LC1 GACCCGGGAGATCTGATTTC
LC2 GATCTGATTTCAGTGGCACAG
LC3 AGTGGCACAGCAGTTACG
LTR2 CACTGCTAGAGATTTTCCAC
LTR3 CCACACTGACTAAAAGGGTC
LTR4 GTCTGAGGGATCTCTAGTT
This table indicates the primers used in the different steps of
generating  the  transgenic  mouse  line.  All  the  primers  are
indicated in a 5'-3' direction and in triplet sets.
BIGH3  cDNA  was  radiolabeled  with  the  random  primed
technique and hybridized to the membrane. Hybridization was
performed with a probe from the vector’s backbone (Figure
1).  Integration  sites  were  also  monitored  by  linear
amplification  mediated  polymerase  chain  reaction  (LAM-
PCR) as described [16]. Briefly, a linear PCR with a long-
terminal repeat (LTR)-specific biotinylated primer (LTR1 in
Table 1) was performed. The specific amplified PCR products
were sorted by magnetic tag selection of extension primers. A
second DNA strand of each target sequence was synthesized
by random hexanucleotide priming. Double-stranded DNA
was digested with CfoI, and an asymmetric ligation cassette
was ligated to the end of CfoI-digested fragments. Nested
exponential PCR amplifications were then performed with
linker cassette (LC)-specific forward primers (LC primers,
Table  1)  and  LTR-specific  reverse  primers  (LTR  primers
Table 1). Primer pairs were LC1-LTR2, LC2-LTR3, and LC3-
LTR4.  Finally,  LAM-PCR  products  were  subcloned  in
pGEM-T easy vector, sequenced, and blasted against mouse
genomic DNA.
Protein extraction: Retina and cornea were removed from
dissected  mouse  eyes.  Proteins  were  extracted  and
homogenized for 10 min in 100 µl ice-cold RIPA buffer,
which consisted of 50 mM Tris-Cl pH 8.0, 150 mM NaCl, 1%
NP-40, 0.5% deoxycholate, and 0.1% SDS, and also contained
protease (Roche, Mannheim, Germany) and 1% phosphatase
(Sigma) inhibitor cocktails. Further homogenization through
a needle was performed when necessary. Retinas or corneas
were homogenized in ice-cold RIPA buffer with an 18 gauge
needle.  Protein  concentrations  were  measured  by
bisinchoninic acid (BCA) protein assay (Pierce, Rockford,
IL).
Western blot analysis: Equal amounts of protein samples were
separated  by  8%  SDS–PAGE  gel  and  transferred  to  a
polyvinylidene difluoride membrane (Westran clear signal;
Whatman  Inc.,  Maidstone,  UK).  Membranes  were  then
blocked for 1 h at room temperature with Tris-buffered saline,
composed of 150 mM NaCl and 50 mM Tris, pH 7.5, and
contained 0.1% Tween (TBS-T) and 5% nonfat dry milk.
Next,  membranes  were  probed  with  a  polyclonal  rabbit
antiserum against human KE-2 (1/4,000) [17] for 2 h in TBS-
T  with  5%  nonfat  dry  milk.  A  secondary  horseradish
peroxydase-coupled  goat  antirabbit  IgG  (1/25,000;
Amersham Biosciences, Buckinghamshire, UK) was used for
1 h at room temperature in TBS-T with 5% nonfat dry milk.
After three washes in TBS-T, the antigen-antibody complexes
were  detected  by  chemiluminescence  using  the  Enhanced
Chemi Luminescence Plus (ECL+) western blotting system
(Amersham  Biosciences).  Results  were  quantified  under
conditions of linearity by integration of the density of total
area of each band using a video densitometer and LabWorks
4.0 software (Media Cybernetics, Bethesda, MD). Results are
expressed as a percentage of the control optical density.
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1131Hematoxylin-eosin and DAPI staining of mouse eyes: Mouse
eyes (8 transgenic and 3 wild type) were dissected and fixed
in  4%  paraformaldehyde  for  1  h.  Fixed  eyes  were  then
embedded in 30% albumin egg, 3% gelatin (Yazzula buffer)
and frozen in liquid nitrogen to be sectioned at 14 µm with a
cryostat. Slides were rehydrated and stained with hematoxylin
for 10 min. After two washes, slides were stained with eosin
for 1 min and fixed in 50% glycerol-50% PBS.
Different slides were stained for 15 min with DAPI safe
from the light and then fixed with FluorSave. In order to
analyze  similar  fields,  we  evaluated  slides  on  which  the
optical nerve was visible on a BX51 Olympus microscope at
100X or 400X magnification. Pictures were taken using CellD
imaging software (Carl Zeiss, Jena, Germany).
Autopsy: Eight-month-old transgenic mice (two males and
two females) and wild-type (one male and one female) living
mice were sent to Frimorfo Inc. (Fribourg, Switzerland) for
an  in  depth  analysis  of  all  organs.  This  analysis  includes
macroscopic  inspection,  necroscopy  and  histopathological
evaluation  completed  by  full  X-ray  analysis  and  blood
analysis (blood chemistry and hematology).
RESULTS
Generation and validation of the transgenic model: In total,
25  independent  PGK-Groenouw  transgenic  founders  were
generated, with a transgene integration averaged ratio of 37%
±18 of the newborns, depending on the lentiviral batch and
titer. In this study, we observed that only batches of lentiviral
particles  titrated  above  1x108  TU/ml  were  effective  in
generating  transgenic  animals.  We  routinely  screened  the
mice by PCR for transgene integration, using primers specific
for  the  transgene  and  RT–PCR  for  transcript  expression
(Figure 2). As described in the previous section, digestion of
endogenous mouse TGFBI/BIGH3 resulted in only one band
whereas  BamHI  digestion  of  transgenic  (human)  TGFBI/
BIGH3 resulted in two bands.
Southern blot analyses were used to evaluate the number
of integration sites in the F1 generation of transgenic mice.
Generally one to four sites were observed (Figure 3A). Based
on the size of the fragments, and assuming no recombination
in the region of the probe, five integration sites were seen in
the Southern blot analysis of transgenic mice. It is assumed
that, with successive generations, the number of integration
sites will diminish. Moreover, localization of integration sites
were  monitored  in  some  transgenic  animals  using  linear
amplification  mediated  polymerase  chain  reaction  (LAM-
PCR) method. Integration of lentiviral vectors were seen in
chromosomes 7, 8, 14, 19, and Y. Table 2 indicates the exact
positions of the identified integration sites.
We additionally monitored tissue expression in glycerol-
embedded sectioned tissues (not shown) and by western blot
using an anti-KE2 antibody in transgenic mice expressing the
R555W mutation under the control of the PGK promoter. KE
expression was slightly increased in the retina of transgenic
mice compared to wild-type mice (Figure 3B, left panel). We
also  observed  a  clear  expression  of  KE  in  the  brain  of
transgenic mice, whereas no expression was found in wild-
type mice (Figure 3B). Overall, it did not seem to affect
endogenous expression in other tissues (Figure 3B, left and
right  panels).  The  figure  also  showed  smaller  bands
corresponding to degradation products of the protein.
Organ  comparisons  between  phosphoglycerate  kinase
promoter-Groenouw  transgenic  and  wild-type  mice:  The
weight of the organs of eight-month-old transgenic mice (two
males  and  two  females)  was  compared  to  age-  and  sex-
matched control mice. Transgenic mice appeared to be healthy
and did not display particular abnormal behavioral signs for
up to 18 months.
Transgenic mice tended to have increased organ size and
weight,  except  for  the  thymus  that  was  reduced  in  size
compared to age-matched wild-type NMRI mice (Table 3).
Transgenic female mice showed follicular hyperplasia (Figure
4,  lower  panel),  increased  amount  of  extramedullary
hematopoiesis,  and  higher  spleen  weights  (Table  3).  The
weight of the heart and kidneys was higher in transgenic
females (Table 3), but morphology was normal.
Figure  2.  Screening  for  transgenic  TGFBI/BIGH3  mRNA
expression. A: The scheme shows the difference between human and
murine TGFBI/BIGH3. Note the localization of the primers used for
the PCR and the unique BamHI site present only in the human gene.
B:  Migration  of  undigested  corneal  (lanes  2  and  4)  or  BamHI
digested retinal (lanes 1 and 3) cDNA amplimers from two different
PGK-Groenouw transgenic mice, as showed in A. L indicates the 1-
kb DNA ladder lane.
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1132We did not observe other differences between males and
females  for  relative  weight  or  histology  of  other  organs,
compared to non-transgenic animals. Overall, no statistical
differences were observed in protein concentrations (Table
4A)  or  in  cell  composition  (Table  4B)  of  blood  between
transgenic mice and wild-type mice. One transgenic female
presented  lipogenic  pigment  accumulation  in  the  adrenal
gland.
Transgenic-dependent  retinal  degeneration:  Transgenic
expression of KE was observed in the retina but not in the
cornea of transgenic animals. We therefore investigated the
effect  of  TGFBI/BIGH3  overexpression  in  retinal  tissue.
While  electroretinogram  (ERG)  response  to  increasing
intensities flashlights were normal in 2-month-old transgenic
mice, we observed a reduction in a- and b-waves in more than
50% of the older mice (Figure 5). In scotopic conditions, at
an illumination of 100 mcds/s, 2-month-old mice showed a
mean b-wave of 346 mV whereas this mean measure falls to
211 mV at 6 month. Four out six (66.7%) mice showed b-
waves even lower than the mean measure. In comparison and
in the same conditions, NMRI wild type mice showed no
difference in mean values from 2 to 6.5 month of age. Mice
Figure  3.  TGFBI/BIGH3  expression  analyzed  by  Southern  and
western blots. A: The Southern blot shows various integration sites
of  the  transgene  in  27  PGK-Groenouw  F1  transgenic  animals
originating from four different founders. B: The Western blot against
TGFBI/BIGH3 of the wild type (left panel) shows no expression in
the retina and the brain in comparison with the western blot of a PGK-
Groenouw  transgenic  mouse  (right  panel).  The  following
abbreviations are used in (B): cornea (C ), retina (R ), brain (B), heart
(H), liver (L), spleen (S), kidney (K), and muscle (M). The arrow
indicates 64 kDa band corresponding to keratoepithelin.
with flat ERG also showed a diminution of the retina thickness
and a global disorganization of the cell disposition in the retina
of  transgenic  mice  expressing  the  Groenouw  mutation
compared to control mice (Figure 6). Quantifications of the
outer and inner nuclear layers thickness showed a significant
diminution of each layer corresponding to a global diminution
in transgenic mice (Figure 6B).
DISCUSSION
Despite many studies on TGFBI/BIGH3 in the development
of human corneal dystrophy, its physiologic role is not yet
entirely understood. To further elucidate the function of the
gene, we generated a transgenic mouse line expressing one of
the major mutant forms of human TGFBI/BIGH3.
TGFBI/BIGH3 expression in our transgenic mouse line
showed  variable  transgene  amount  expressed  in  different
organs. However, our results consistently showed not only a
clear overexpression of the protein in the heart and the kidney
but a protein expression appeared in the retina and in the brain
(Figure 3). Transgene expression of human TGFBI/BIGH3
was also observed in other organs, but to a lesser extent.
TABLE 2. LOCATION OF VIRUS INTEGRATION SITES IN TRANSGENIC MICE
Chromosome Contig Position Mouse ID
7 NT_039407.1 1329488 708, 718
8 NT_081820.1 303322 705, 724
8 NT_039456.3 12023612 703, 708
718, M15
M129, M130
M139, M142
M165, M172
M176, M178
M179, M191
M196
14 NT_039606.7 34668 708
19 NT_039689.1 3483949 708
17 different mice (Mouse ID) have been submitted to linear
amplification  mediated  polymerase  chain  reaction  (LAM-
PCR). Five different integration sites have been identified,
and each of them is characterized by its chromosome, its
contig and its exact position.
TABLE 3. MEAN ORGAN WEIGHT OF TRANSGENIC AND WILD-TYPE MICE.
Organ Mean weight (grams)
Transgenic (SEM) Control (SEM)
Body weight 46.65 (14.84) 38.85 (10.82)
Brain 1.21 (0.46) 1.245 (0.40)
Spleen 0.39 (0.22) 0.26 (0.07)
Liver 5.405 (1.62) 4.07 (0.30)
Left Kidney 0.94* (0.13) 0.675 (0.02)
Right Kidney 0.935* (0.10) 0.675 (0.06)
Heart 0.505 (0.12) 0.39 (0.03)
Thymus 0.06 (0.04) 0.08 (0.04)
Four transgenic and two wild-type mice were sacrificed and
weighed. SEM indicates the standard deviation observed for
each  organs,  and  asterisk  indicate  significant  differences
between transgenic and wild-type organ (the asterisk denotes
a p<0.05).
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1133Usually, viral vectors are known to randomly integrate in
the host genome. However, a report by Hacein-Bey-Abina and
colleagues [18] challenged this assumption, and the idea of
preferred  integration  sites  for  viral  vectors  emerged.  The
integration  sites  varied,  depending  on  the  type  of  virus
implicated, and occurred within active transcription units and
more particularly, within or near genes encoding for proteins
with kinase, transferase function, or phosphorylation activity
[19,20]. As seen in Figure 3, several transgenic mice shared a
same integration site on chromosome 8 (Table 2). We didn’t
find any gene with retina-specific transcript in this region. The
technique used did not allow us to identify all integration sites,
and  it  is  likely  that  other  chromosomes  regions  harbored
Figure 4. Hyperplasia histology analysis of the spleen in a transgenic
mouse compared to a wild type mouse. Shown is a hematoxylin-eosin
coloration of spleen taken from an eight-month-old wild type (A)
mouse and an eight-month-old transgenic (B) mouse. Hyperplasia of
the folliculi in the transgenic mice can be seen in (B). Both pictures
were taken at 100X magnification.
transgenes. This is corroborated by the results of the Southern
blots showing more than two sites of integration.
Transgenic animals did not present apparent macroscopic
abnormalities compared to control mice, suggesting that KE
overexpression did not severely impair mouse development.
Previous studies showed that TGFBI/BIGH3 is involved in
cell  growth,  tumor  genesis,  wound  healing,  apoptosis,
migration, and osteogenesis among others [21]. This could
mean that such actions are under the control of domains not
mutated  in  our  experiments.  Results  of  blood  analysis
suggested that no metabolic change occurred in transgenic
mice  (Table  4).  Moreover,  no  evident  differences  were
observed  at  the  cellular  level  except  for  spleen  follicular
hyperplasia in the transgenic female animals (Figure 4). We
did not obtain any measurable KE expression in the cornea of
transgenic animals with the promoter tested (Figure 3). This
lack of expression was not due to transcriptional silencing
since no transgene insertion was observed in DNA extracted
from corneas (Figure 2). A possible explanation could be the
TABLE 4. BLOOD CHEMISTRY AND HEMATOLOGY OF TRANSGENIC AND WILD-TYPE MICE.
A
Blood Chemistry Transgenic Control
Serum Glucose (mmol/l) 9.08 7.60
Urea (mmol/l) 11.67 9.15
Creatinine (μmol/l) 25.00 18.00
Protein (Biuret; g/l) 69.37 49.65
Albumin (g/l) 41.44 30.35
Cholesterin (mmol/l) 5.07 3.10
ASAT (GOT; U/l) 90.33 63.50
ALAT (GPT; U/l) 50.33 30.50
CK (U/l) 376.00 220.50
Amylase (U/l) 4707.27 3376.70
Calcium (mmol/l) 3.07 2.24
Phosphate (mmol/l) 2.46 1.67
Sodium (mmol/l) 209.60 156.85
Potassium (mmol/l) 6.09 4.45
B
Hematology Transgenic Control
Hematocrit (%) 0.455 0.43
Hemoglobin (g/l) 161.5 158
Erythrocytes (x1012/l) 9.53 9.32
Leukocytes (x109/l) 5 5.3
MCH (pg) 16.75 17
MCHC (g/l) 354.5 367
MCV (fl) 48 46
Thrombocytes (x109/cl) 13.96 12.45
Banded Neutrophils (%) 0.375 0.25
Segmented Neutrophils (%) 22.5 12.75
Eosinophils (%) 2.125 1.25
Monocytes (%) 1.125 1
Lymphocytes (%) 73.875 84.75
Segmented Neutrophils (x109/l) 1.2 0.71
Eosinophils (x109/l) 0.1275 0.06
Lymphocytes (x109/l) 3.5725 4.445
Blood was removed from four transgenic and two wild-type
mice.  Mean  measures  have  been  measured  for  blood
chemistry (A) and hematology (B) in transgenic and wild-type
mice. Abbreviations in the table: ASAT is aspartate amino
transferase;  ALAT  is  alanine  amino  transferase;  CK  is
creatinine kinase; MCH is mean corpuscular hemoglobin;
MCHC is mean corpuscular hemoglobin concentration; MCV
is mean corpuscular volume.
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1134systematic elimination of corneal cells overexpressing the
transgene.  Alternatively,  this  could  be  the  result  of  an
embryonic  selection  of  corneal  cells  devoid  of  transgene,
since  we  previously  described  that  overexpression  of  KE
induce apoptosis in cell lines [22]. It is possible that the KE
silencing in the cornea might be consecutive to the method
used to generate transgenic animals. Such a selection process
may not be present later in life as Bainbridge et al. [7] showed
stable transgenic expression in corneal endothelium when the
transgene was directly injected in the anterior chamber. A
Figure 5. Electroretinogram analysis of transgenic mice at various
ages.  A:  Amplitudes  of  b-waves  of  PGK-Groenouw  transgenic
mice’s electroretinogram (ERG) distributed in function of their age.
B:  ERG  recordings  in  response  to  single  flashes  in  scotopic
conditions.  Two  different  six-month-old  PGK-BIG  Groenouw
transgenic animals showed either a normal response (upper panel) or
a flat ERG (lower panel). Conditions: A1 to V1 shows records with
increasing intensities of light from 0.1 to 25000 mcds/m2 and each
division of the time axis correspond to 40 ms. U1 to j1 shows records
with increasing frequencies of flashlight from 0.5 to 30 Hz and each
division of the time axis correspond to 50 ms.
transgenic mouse generated with the traditional method might
also generate another expression pattern.
Interestingly,  we  observed  an  age-dependent  retinal
degeneration in transgenic mice that was not seen in wild-type
controls (Figure 6). The observation was confirmed by ERG
analyses (Figure 5). Moreover, lipogenic pigments were also
observed  in  transgenic  mice.  This  pigment  is  common  in
normal aging mice, but rare before 18 months of age. The
presence of this pigment in our transgenic mice suggests an
accelerated aging process that may explain in part the retinal
degeneration.  The  follicular  hyperplasia  observed  in  the
spleen was found only in female mutants. Again, this finding
is  relatively  common  in  6-month-old  wild-type  mice  and
increases in frequency with age, which is consistent with an
accelerated  aging  process.  A  study  by  Kuro-o  et  al.  [23]
described  a  transgenic  mouse  line  leading  to  a  syndrome
resembling human aging. The results showed a short lifespan,
infertility, and arteriosclerosis, among others. Interestingly,
the  authors  also  noted  a  slight  increase  in  calcium  and
phosphorus in blood serum, accompanied with a diminution
Figure 6. Measurement of the outer nuclear layer of the retina in
transgenic and wild-type mice. A: Retinas of a wild type (left panel)
and of a PGK-Groenouw transgenic (right panel) mouse stained with
hematoxilin-eosin. The bars indicate the outer nuclear layer (ONL)
of the retina. The pictures were taken at a 600X magnification. B:
ONL and outer plus inner nuclear layer (INL-ONL) of retinas from
control  nontransgenic  (Ctl)  and  PGK-Groenouw  transgenic  (Tg)
mice at 16 months of age were measured and quantified in the graph.
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1135of  leukocytes  and  lymphocytes.  We  also  observed  this
tendency  in  our  data  (Table  4)  but  our  results  are  not
statistically  significant  (p=0.59  and  0.65  for  difference  in
calcium and lymphocyte concentrations respectively). This
study also noted growth retardation in transgenic mice, which
is in accordance with our results. On the other hand, Olsson
et al. [24] showed that overexpression of normal proteins can
damage  photoreceptors  because  of  protein  trafficking
abnormalities. This observation may be in accordance with
the retinal degeneration observed in transgenic mice, but does
not explain the early presence of lipogenic pigment and the
follicular hyperplasia.
In  conclusion,  we  generated  a  transgenic  mouse  line
expressing  an  R555W  human  mutated  TGFBI/BIGH3.
Extensive histopathological evaluation, completed by full X-
ray  and  blood  analysis  showed  no  evident  differences
compared to wild-type mice, except for retinal degeneration.
The transgenic mice seemed to grow quicker than wild-type
mice, as they tended to be bigger than age-matched wild-type
mice.  The  presence  of  lipogenic  pigment,  the  retinal
degeneration,  and  the  follicular  hyperplasia  of  the  spleen
observed in the transgenic mice suggest an accelerated aging
process.
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